BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29167148)

  • 1. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
    Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
    Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
    Shimojo N; Jesmin S; Zaedi S; Maeda S; Soma M; Aonuma K; Yamaguchi I; Miyauchi T
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H835-45. PubMed ID: 16501010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER mediates estrogen cardioprotection against epinephrine-induced stress.
    Fu L; Zhang H; Ong'achwa Machuki J; Zhang T; Han L; Sang L; Wu L; Zhao Z; James Turley M; Hu X; Hou H; Li D; E Harding S; Sun H
    J Endocrinol; 2021 May; 249(3):209-222. PubMed ID: 33847279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of the G protein-coupled estrogen receptor (GPER) prevents and regresses cardiac hypertrophy.
    Di Mattia RA; Mariángelo JIE; Blanco PG; Jaquenod De Giusti C; Portiansky EL; Mundiña-Weilenmann C; Aiello EA; Orlowski A
    Life Sci; 2020 Feb; 242():117211. PubMed ID: 31891720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
    Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1.
    Pedram A; Razandi M; Aitkenhead M; Levin ER
    J Biol Chem; 2005 Jul; 280(28):26339-48. PubMed ID: 15899894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
    Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
    Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension.
    Zhu LA; Fang NY; Gao PJ; Jin X; Wang HY; Liu Z
    Curr Vasc Pharmacol; 2015; 13(4):467-74. PubMed ID: 25360842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and signaling of G protein-coupled estrogen receptor 1 (GPER) in rat sertoli cells.
    Lucas TF; Royer C; Siu ER; Lazari MF; Porto CS
    Biol Reprod; 2010 Aug; 83(2):307-17. PubMed ID: 20445128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca(2+)-sensitive tyrosine kinase Pyk2/CAK beta-dependent signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy.
    Hirotani S; Higuchi Y; Nishida K; Nakayama H; Yamaguchi O; Hikoso S; Takeda T; Kashiwase K; Watanabe T; Asahi M; Taniike M; Tsujimoto I; Matsumura Y; Sasaki T; Hori M; Otsu K
    J Mol Cell Cardiol; 2004 Jun; 36(6):799-807. PubMed ID: 15158121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling.
    Patten RD; Pourati I; Aronovitz MJ; Baur J; Celestin F; Chen X; Michael A; Haq S; Nuedling S; Grohe C; Force T; Mendelsohn ME; Karas RH
    Circ Res; 2004 Oct; 95(7):692-9. PubMed ID: 15345655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
    Jesus ICG; Scalzo S; Alves F; Marques K; Rocha-Resende C; Bader M; Santos RAS; Guatimosim S
    Am J Physiol Cell Physiol; 2018 Jun; 314(6):C702-C711. PubMed ID: 29443552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
    Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
    Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPER-independent effects of estrogen in rat aortic vascular endothelial cells.
    Ding Q; Hussain Y; Chorazyczewski J; Gros R; Feldman RD
    Mol Cell Endocrinol; 2015 Jan; 399():60-8. PubMed ID: 25150623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
    Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
    Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.
    Pei H; Wang W; Zhao D; Su H; Su G; Zhao Z
    Int J Biol Sci; 2019; 15(1):81-92. PubMed ID: 30662349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of peptidyl-prolyl isomerase Pin1 in the inhibitory effect of fluvastatin on endothelin-1-induced cardiomyocyte hypertrophy.
    Sakai S; Shimojo N; Kimura T; Tajiri K; Maruyama H; Homma S; Kuga K; Mizutani T; Aonuma K; Miyauchi T
    Life Sci; 2014 May; 102(2):98-104. PubMed ID: 24657892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.